Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Werner

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Gynecologic Oncology|July 5, 2014
Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterationsE Wik, J Trovik, K Kusonmano, et al.
Cancer Cell|October 7, 2015
The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human CancersLeng Han, Lixia Diao, Shuangxing Yu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2016
Changes in Chromatin Structure in Curettage Specimens Identifies High-Risk Patients in Endometrial CancerTarjei S Hveem, Tormund S Njølstad, Birgitte Nielsen, et al.
Annals of Surgical Oncology|May 13, 2022
Adjuvant Use of PlasmaJet Device During Cytoreductive Surgery for Advanced-Stage Ovarian Cancer: Results of the PlaComOv-study, a Randomized Controlled Trial in The NetherlandsG M Nieuwenhuyzen-de Boer, W Hofhuis, N Reesink-Peters, et al.
Nature Communications|January 29, 2015
Corrigendum: A pan-cancer proteomic perspective on The Cancer Genome AtlasRehan Akbani, Patrick Kwok Shing Ng, Henrica M J Werner, et al.
Nature Genetics|June 28, 2016
The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasisWilliam J Gibson, Erling A Hoivik, Mari K Halle, et al.
Nature Communications|May 30, 2014
A pan-cancer proteomic perspective on The Cancer Genome AtlasRehan Akbani, Patrick Kwok Shing Ng, Henrica M J Werner, et al.
American Journal of Obstetrics and Gynecology|May 21, 2021
Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancerWillem Jan van Weelden, Roy I Lalisang, Johan Bulten, et al.
Cancers|June 19, 2024
Hormone Receptor Expression and Activity for Different Tumour Locations in Patients with Advanced and Recurrent Endometrial CarcinomaMaartje M W Luijten, Willem Jan van Weelden, Roy I Lalisang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 12, 2018
Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration StudyLouis J M van der Putten, Nicole C M Visser, Koen van de Vijver, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Gynecologic Oncology|July 5, 2014
Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterationsE Wik, J Trovik, K Kusonmano, et al.
Cancer Cell|October 7, 2015
The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human CancersLeng Han, Lixia Diao, Shuangxing Yu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2016
Changes in Chromatin Structure in Curettage Specimens Identifies High-Risk Patients in Endometrial CancerTarjei S Hveem, Tormund S Njølstad, Birgitte Nielsen, et al.
Annals of Surgical Oncology|May 13, 2022
Adjuvant Use of PlasmaJet Device During Cytoreductive Surgery for Advanced-Stage Ovarian Cancer: Results of the PlaComOv-study, a Randomized Controlled Trial in The NetherlandsG M Nieuwenhuyzen-de Boer, W Hofhuis, N Reesink-Peters, et al.
Nature Communications|January 29, 2015
Corrigendum: A pan-cancer proteomic perspective on The Cancer Genome AtlasRehan Akbani, Patrick Kwok Shing Ng, Henrica M J Werner, et al.
Nature Genetics|June 28, 2016
The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasisWilliam J Gibson, Erling A Hoivik, Mari K Halle, et al.
Nature Communications|May 30, 2014
A pan-cancer proteomic perspective on The Cancer Genome AtlasRehan Akbani, Patrick Kwok Shing Ng, Henrica M J Werner, et al.
American Journal of Obstetrics and Gynecology|May 21, 2021
Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancerWillem Jan van Weelden, Roy I Lalisang, Johan Bulten, et al.
Cancers|June 19, 2024
Hormone Receptor Expression and Activity for Different Tumour Locations in Patients with Advanced and Recurrent Endometrial CarcinomaMaartje M W Luijten, Willem Jan van Weelden, Roy I Lalisang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 12, 2018
Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration StudyLouis J M van der Putten, Nicole C M Visser, Koen van de Vijver, et al.
Pageof 10